Icon: enlarge
Health Minister Jens Spahn (CDU)
Photo:
Oliver Ziebe / dpa
The federal government has bought a new antibody-based corona drug for Germany.
»From next week, the monoclonal antibodies will be used in Germany as the first country in the EU.
First in university clinics, "said Federal Health Minister Jens Spahn (CDU) of" Bild am Sonntag ".
"The federal government has bought 200,000 cans for 400 million euros," said Spahn.
The then US President Donald Trump was treated with this form of antibodies after his corona infection.
“They act like a passive vaccination.
The administration of these antibodies can help high-risk patients in the early phase to prevent a severe course, «says Spahn.
The antibody cocktail that Trump received shortly after his diagnosis is made by the US biotech company Regeneron.
It contains two antibodies that are directed against a key protein of Sars-CoV-2.
In therapy with the agent, patients receive artificially generated antibodies that are supposed to attach to the coronavirus and prevent it from entering cells.
The virus can only multiply there.
For this reason, antibody therapies are linked to two different hopes.
On the one hand, they are supposed to protect infected people from severe disease.
In addition, they may also protect healthy people from infection and can therefore be used by doctors and nurses until they are vaccinated.
Icon: The mirror
svv
